Department of Dermatology

Multicomponent compression system use in patients with chronic venous insufficiency: A real-life prospective study (2021) Stücker M, Münter KC, Erfurt-Berge C, Lützkendorf S, Eder S, Möller U, Dissemond J Journal article, Review article Factors influencing the adjuvant therapy decision: Results of a real-world multicenter data analysis of 904 melanoma patients (2021) Lodde G, Forschner A, Hassel J, Wulfken LM, Meier F, Mohr P, Kähler K, et al. Journal article Increased prevalence of irritant hand eczema in health care workers in a dermatological clinic due to increased hygiene measures during the SARS-CoV-2 pandemic (2021) Reinholz M, Kendziora B, Frey S, Oppel EM, Rueff F, Clanner-Engelshofen BM, Heppt M, et al. Journal article NanoString technology distinguishes anti-TIF-1γ+ from anti-Mi-2+ dermatomyositis patients (2021) Preusse C, Eede P, Heinzerling L, Freitag K, Koll R, Froehlich W, Schneider U, et al. Journal article Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy – A multicentre study of 90 patients from the German Dermatooncology Group (2021) Grimmelmann I, Momma M, Zimmer L, Hassel JC, Heinzerling L, Pföhler C, Loquai C, et al. Journal article HIV-1 Nef-Induced Secretion of the Proinflammatory Protease TACE into Extracellular Vesicles Is Mediated by Raf-1 and Can Be Suppressed by Clinical Protein Kinase Inhibitors (2021) Zhao Z, Fagerlund R, Baur A, Saksela K Journal article Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification (2021) Höhn J, Krieghoff-Henning E, Jutzi TB, von Kalle C, Utikal JS, Meier F, Gellrich FF, et al. Journal article Sustainable responses in metastatic melanoma patients with and without brain metastases after elective discontinuation of anti-PD1-based immunotherapy due to complete response (2021) Dimitriou F, Zaremba A, Allayous C, Kähler KC, Gerard CL, Festino L, Schäfer S, et al. Journal article Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition (2021) Knispel S, Gassenmaier M, Menzies AM, Loquai C, Johnson DB, Franklin C, Gutzmer R, et al. Journal article Select hyperactivating NLRP3 ligands enhance the TH1-and TH17-inducing potential of human type 2 conventional dendritic cells (2021) Hatscher L, Lehmann C, Purbojo A, Onderka C, Liang C, Hartmann A, Cesnjevar R, et al. Journal article, Original article